# Enanta Pharmaceuticals Inc: Form DEF 14A, filed Jan 27, 2025

- Company: [Enanta Pharmaceuticals Inc](/companies/enta.md) (CIK 1177648)
- Form: DEF 14A
- Filed: 2025-01-27
- Accepted by EDGAR: Jan 27, 2025, 16:00 ET
- Period: 2025-03-13
- Accession: 0000950170-25-009168
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1177648/000095017025009168/enta-20250127.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1177648/000095017025009168/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1177648/000095017025009168/enta-20250127.htm

Filed Jan 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-009168. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.